CSIMarket


Tarsus Pharmaceuticals Inc   (NASDAQ: TARS)
Other Ticker:  
 

Tarsus Pharmaceuticals Inc

TARS's Fundamental analysis








Looking into Tarsus Pharmaceuticals Inc growth rates, revenue grew by 183.68 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 104

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 12.55 %

Tarsus Pharmaceuticals Inc net loss decreased from $-36 millions, to $-25 millions in first quarter of 2025,

More on TARS's Growth


Tarsus Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Tarsus Pharmaceuticals Inc realized cash reduction of $ -0.39 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.75.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.


More on TARS's Valuation
 
 Total Debt (Millions $) 72
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 9,346,960
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.57
 Tangible Book Value (Per Share $) 8.50

Tarsus Pharmaceuticals Inc
realized net loss in trailing twelve months.

Tarsus Pharmaceuticals Inc realized cash outflow of $ -0.39per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.75.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.

Tarsus Pharmaceuticals Inc Price to Book Ratio is at 8.02 lower than Industry Avg. of 2100.73. and higher than S&P 500 Avg. of 0.02

More on TARS's Valuation

  Market Capitalization (Millions $) 2,746
  Shares Outstanding (Millions) 39
  Employees 25
  Revenues (TTM) (Millions $) 234
  Net Income (TTM) (Millions $) -105
  Cash Flow (TTM) (Millions $) -15
  Capital Exp. (TTM) (Millions $) -7
  Total Debt (Millions $) 72
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 9,346,960
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 5.57
  Tangible Book Value (Per Share $) 8.50

  Market Capitalization (Millions $) 2,746
  Shares Outstanding (Millions) 39
  Employees 25
  Revenues (TTM) (Millions $) 234
  Net Income (TTM) (Millions $) -105
  Cash Flow (TTM) (Millions $) -15
  Capital Exp. (TTM) (Millions $) -7





  Ratio
   Capital Ratio (MRQ) 5.57
  Total Debt to Equity (MRQ) 0.21
  Tangible Leverage Ratio (MRQ) 0.47
  Asset Turnover Ratio (TTM) 0.57
  Inventory Turnover Ratio (TTM) 6.32





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.